Bortezomib will raise the amount or impact of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Greater flibanserin adverse effects may arise if coadministered with multiple weak CYP3A4 inhibitors. levoketoconazole will increase the stage or impact of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of... https://marjaneyb332pbl5.bligblogging.com/profile